Alexander Randolph Advisory’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$966K Sell
12,350
-217
-2% -$17.5K 0.8% 25
2026
Q1
$1.09M Hold
12,567
0.94% 22
2025
Q4
$1.21M Hold
12,567
1% 23
2025
Q3
$1.2M Hold
12,567
0.99% 22
2025
Q2
$1.1M Sell
12,567
-150
-1% -$12.7K 0.98% 26
2025
Q1
$1.14M Sell
12,717
-784
-6% -$70.2K 1.12% 22
2024
Q4
$1.08M Sell
13,501
-23
-0.2% -$1.99K 1% 25
2024
Q3
$1.22M Hold
13,524
1.08% 26
2024
Q2
$1.06M Hold
13,524
1% 26
2024
Q1
$1.18M Sell
13,524
-25
-0.2% -$2.13K 1.03% 26
2023
Q4
$1.12M Buy
+13,549
New +$1.03M 1.01% 26

Other funds holding MDT

Alexander Randolph Advisory's MDT Position: Q2 2026 in Review

Alexander Randolph Advisory reduced its Medtronic (MDT) stake by 1.7% in Q2 2026, selling an estimated $17.5K and leaving 12,350 shares worth $966K. The position accounts for 0.8% of the portfolio, ranked #25.

Alexander Randolph Advisory first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.22M in Q3 2024. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Alexander Randolph Advisory held 12,350 shares of Medtronic worth $966K as of Q2 2026.
  • Alexander Randolph Advisory sold 217 Medtronic shares in Q2 2026, an estimated $17.5K.
  • Medtronic made up 0.8% of Alexander Randolph Advisory's portfolio in Q2 2026, its #25 holding.
  • Alexander Randolph Advisory first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • Alexander Randolph Advisory's Medtronic position peaked at $1.22M in Q3 2024.
  • 2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Alexander Randolph Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.